ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW Payout vs PGIM India Healthcare Fund Direct Plan - Growth
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW Payout |  PGIM India Healthcare Fund Direct Plan - Growth | |
|---|---|---|
| NAV | ₹26.35 | ₹12.54 |
| NAV date | 2026-08-19 | 2026-08-18 |
| 1 year | +0.30% | +23.91% |
| 3 year (p.a.) | +13.91% | +14.26% |
| 5 year (p.a.) | +7.90% | +14.26% |
| Expense ratio | 0.87% | 0.80% |
| Fund size | ₹6453.52 Cr | ₹95.49 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.